NCT03853200 is a Phase 2, PHASE3 clinical trial of QMix Root Canal Irrigant in Endodontic Disease, sponsored by Dow University of Health Sciences.

Who is sponsoring NCT03853200?

NCT03853200 is sponsored by Dow University of Health Sciences.

What drugs are being tested in NCT03853200?

Interventions in NCT03853200: QMix Root Canal Irrigant, 17%EDTA+2%Chlorhexidine, EDTA.

What condition does NCT03853200 study?

NCT03853200 studies Endodontic Disease, Root Canal Infection.

Is NCT03853200 still recruiting?

NCT03853200 is currently completed. Last updated 25 February 2019.

Last reviewed 2019-02-25 · How we verify

NCT03853200

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Antibacterial Efficacy of Three Final Irrigants

Completed Phase 2, PHASE3 Last updated 25 February 2019

What this trial tests

Phase 2, PHASE3 trial testing QMix Root Canal Irrigant in Endodontic Disease in 90 participants. Completed in 1 February 2018.

Timeline

3 April 2017

Primary endpoint
1 February 2018

1 February 2018

Quick facts

Lead sponsor	Dow University of Health Sciences
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	3 April 2017
Primary completion	1 February 2018
Estimated completion	1 February 2018
Sites	1 location across Pakistan

Drugs / interventions tested

QMix Root Canal Irrigant — full drug profile →
17%EDTA+2%Chlorhexidine — full drug profile →
EDTA

Conditions studied

Endodontic Disease — all drugs for Endodontic Disease →
Root Canal Infection — all drugs for Root Canal Infection →

Sponsor

Dow University of Health Sciences

Who can join

Eligibility, any sex, with Endodontic Disease or Root Canal Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to determine the antibacterial affect of three different solutions used as final irrigant during endodontic therapy. The investigator's objective was to compare the antibacterial affect of relatively new final irrigant QMix with EDTA and Qmix with EDTA+CHX by evaluating the bacteriological status of the root canal before and after use of the final irrigant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Endodontic Disease

Currently open trials in the same condition.

NCT07239505 — A Randomized Controlled Trial Evaluating Whether Pre-operative Trinase Reduces Post-operative Pain in Patients With Symp · NA · recruiting
NCT06948162 — Exploration of the Utility of Dental-dedicated MRI for Dentistry · recruiting
NCT06574152 — Effect of Photobiomodulation on Pain and Healing of the Vertical Releasing Incision After Endodontic Microsurgery · NA · recruiting
NCT05935306 — Effect of Photobiomodulation to Reduce Post-operative Pain After Endodontic Surgery · NA · recruiting
NCT06660797 — Irrigation Activating Techniques on Irrigant Penetration Depth and Microbial Reduction · NA · recruiting

Other Dow University of Health Sciences trials

Trials by the same sponsor.

NCT07264829 — This Clinical Trial Aims to Compare the Effectiveness of Two Intra-pulpal Cryotherapy Techniques-Endo-ice and Ice Sticks · NA · not yet recruiting
NCT07526818 — Comparison of Manual and Mechanical Glide Path Techniques for Measuring Root Canal Length Using Standalone Apex Locator · NA · active not recruiting
NCT07433374 — COMPARISON OF THE EFFICIENCY OF MANUAL SINGLE HEADED AND TRIPLE HEADED TOOTHBRUSHES IN REMOVING DENTAL PLAQUE AND USER E · NA · completed
NCT07277621 — Behavioral Interventions to Reduce Social Media Addiction Among School-Going Adolescents in Karachi · NA · completed
NCT07323771 — Improving Oral Health Knowledge and Habits in People With Diabetes Through a Theory Guided WhatsApp Education Program · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03853200 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dow University of Health Sciences
Last refreshed: 25 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03853200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing